🚨 DEADLINE REMINDER: Today is the last day to submit an abstract, apply for an award, and register at a discount for #SLAM2026! slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology

Original post on mastodon.social

“ Rare phantom pain linked to liver cancer
A leading oncologist has warned that persistent right-sided shoulder pain could be an overlooked early sign of liver cancer. The symptom, known as 'phantom pain', arises when liver irritation is perceived in the shoulder due to shared nerve pathways […]

⏳ ONE DAY LEFT! Finalize your #SLAM2026 abstract submission and award application for the March 31 deadline! slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology #ASIPmeeting

These speakers at #SLAM2026 will discuss metabolism and microbiome! Learn more at slam26.asip.org

#LiverResearch #LiverCancer #LiverDisease #Hepatology #ASIPmeeting

Characteristic Genomic and Clinicopathologic Landscape of DNA Polymerase Epsilon Mutant Colorectal Adenocarcinomas – A Retrospective Cohort Study DNA polymerase epsilon catalytic subunit A (POLE) gene plays a crucial role in DNA repair and chromosomal replication. Mutations in the POLE gene have been linked to cancer, particularly colorectal carcinoma (CRC). However, the genomic landscape and pathological significance of POLE mutant CRC remain underreported. This study aimed to characterize the clinicopathologic features and genomic landscape of CRC harboring POLE mutations and to investigate the implications of co-occurring genetic alterations.

🧬 Can AI predict liver cancer survival? A new study shows that machine learning models can help forecast outcomes in liver cancer patients, offering potential to support clinical decision-making.
#AI #LiverCancer #MachineLearning #HCC
www.xiahepublishing.com/2310-8819/JC...

Congratulations to #AusHSI PhD student Inosha Alwis, who recently presented a very engaging PhD confirmation seminar on patient preferences and the cost-effectiveness of novel methods for surveillance of hepatocellular carcinonoma, the most prevalent type of primary #livercancer.

Yesterday at the European Parliament, DiCE joined “Accelerating action: scaling up liver cancer prevention through hepatitis elimination.”
#LiverCancer is already the EU’s 6th leading cause of cancer death, yet much of it is preventable. Stigma around #hepatitis still delays care.

🆕A new modelling study in #HongKong found one-off screening in #Prison is cost-effective to reduce #HCV related #cirrhosis, #LiverCancer & #mortality. More frequent screenings imply higher cost, but would yield better health gain.

🔗 Full text: tinyurl.com/47czn484
#MedSky #OncSky #HepatitisC

⏰ ONE WEEK LEFT! Prepare your #SLAM2026 abstract submission and award application for the March 31 deadline! slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology #ASIPmeeting

Modeling liver cancer caused by chronic hepacivirus infection. Great collab with Rice Lab
@rockefeller.edu
heavy lift by Mariana Batista #HCV #HCC #livercancer #cancer #chronicinfection
doi.org/10.1016/j.jh...

These speakers at #SLAM2026 will discuss novel technologies for liver research, plus feature two abstract-driven talks! Learn more at slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology #ASIPmeeting

Very happy to be in Bristol to present our work on #bacterial #omics in #hepatocellular #carcinoma!

Oral presentation O3 at the HCC-UK 2026 Congress.

Roger Williams Inst. of Liver Studies
@kingscollegelondon.bsky.social

#hcc #liver #cancer #livercancer #gut #microbiome #microbiota #hccuk2026

⚓ As a child of immigrants, this has been my lifelong understanding of #StPatricksDay ☘️🍺🤢

Also, #Cirrhosis #AlcoholInducedEncephalopathy #LiverCancer etc

Our sixth annual Liver Tumor Multidisciplinary Symposium was a tremendous success! Thank you to our expert speakers, hospital leadership, and the attendees for coming together to discuss the latest innovations in liver tumor care. Looking forward to next year already 🌟
#LiverCancer

⏲️ LIVER RESEARCHERS: Two weeks left to check these off your to-do list for #SLAM2026:
✅Submit your abstract
✅Register
✅Submit your award application - ASIP and AASLD members are eligible!

See details at http://slam26.asip.org
#LiverResearch #LiverDisease #LiverCancer #Hepatology #ASIPmeeting

🚨 Call for Papers!
Ther Adv Med Onc invites submissions to our Special Collection on combined immunotherapy for advanced HCC.
🗓 Deadline: 30 Oct 2026
🔗 Submit: buff.ly/e8XA6kU
#HCC #LiverCancer #Immunotherapy #Oncology

Study reveals how a rare pediatric liver cancer emerges and its response to therapy The findings provide a new developmental model of pediatric liver cancer

This study provides a new developmental model of pediatric #liverCancer, linking early liver development to tumor heterogeneity, tumor-type transitions and patient outcomes. P. Sumazin et al @jhepatology.bsky.social @bcmhouston.bsky.social #ChildhoodCancer #WNT blogs.bcm.edu/2026/03/12/f...

Regulatory mechanisms of ALKBH5/CIITA axis in the synergistic modulation of hepatocellular carcinoma radiotherapy and immunotherapy - Genes & Immunity Genes & Immunity - Regulatory mechanisms of ALKBH5/CIITA axis in the synergistic modulation of hepatocellular carcinoma radiotherapy and immunotherapy

🌅 #Research #Alert
Regulatory #mechanisms of ALKBH5/CIITA axis in the #synergistic modulation of #hepatocellular #carcinoma #radiotherapy and #immunotherapy
#livercancer #liver #cancer #immunology

@springernature.com #Genes & #immunity
www.nature.com/articles/s41...

These speakers at #SLAM2026 will discuss MASH and fibrosis, plus feature two abstract-driven talks! Learn more at slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology #ASIPmeeting

¿Por qué el cáncer de hígado es más común en Asia? 🌏
Factores como hepatitis viral, toxinas alimentarias y diferencias en salud pública influyen en las tasas.

🎥 Mira el video para conocer las tendencias globales y terapias clave en oncología.

#LiverCancer #Oncology #CancerTreatment #GlobalHealth

New MRI scoring system predicts early liver cancer recurrence The system performed better for this indication than pathologic analysis-based prognostic models.

The system performed better for this indication compared to pathologic analysis-based prognostic assessments #radiology #livercancer #MRI

Grateful to everyone who came to the 6th annual Liver Tumor Multidisciplinary Symposium. Special thanks to Pete Healy, President, BIDMC, for his opening remarks. Together, we will share research discoveries, advance clinical practice, and improve outcomes for patients with #livercancer.

These speakers at #SLAM2026 will discuss stem cells and organoids, plus feature two abstract-driven talks! Learn more at slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology #ASIPmeeting

CEUS with perfluorobutane diagnoses small-cell HCC Contrast-enhanced ultrasound (CEUS) with perfluorobutane performs well in diagnosing small-cell liver hepatocellular carcinoma (HCC).

CEUS with perfluorobutane achieved a similar performance to MRI when incorporating Kupffer-phase findings, regardless of whether patients have cirrhosis or not #radiology #CEUS #ultrasound #MRI #livercancer

Promising findings by Hiroshima University researchers. In chronic #HepatitisB #HepB, #HBV #RNA may better predict #livercancer risk than current markers, even when viral DNA is undetectable. This could help identify patients who need closer monitoring earlier. www.linkedin.com/posts/drmelv...

🗓️ ONE MONTH COUNTDOWN: Start preparing your abstract and register early to save for #SLAM2026! slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology #ASIPmeeting

#cansky #oncsky #oncology #stomachcancer #coloncancer #colorectalcancer #pancreaticcancer #livercancer #esophagealcancer #oncology

These speakers at #SLAM2026 will discuss plasticity and transdifferentiation, plus feature two abstract-driven talks! Learn more at slam26.asip.org

#LiverResearch #LiverDisease #LiverCancer #Hepatology #ASIPmeeting

#AspirinCancer
🩺 Lowers risk in liver, breast, and colorectal cancer (IBD).
⚠️ Raises mortality risk in 70+; not for general prevention.
🤔 Evidence is mixed—consult a doctor.
#AspirinCancer #LiverCancer #BreastCancer #ColorectalCancer #OlderAdults
View in Timelines

& #livercancer @who.int data show that birth-dose HBV💉rates in 🇺🇸 ⏫️ from ~ 21% 2002 ➡️66% ➡️75% in 2019, trends mirrored in CDC National Immunization Survey data. However, recent HBV vaccination rates remain unknown, representing a critical gap given increasing concerns about vaccine hesitancy